SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Abraham Lincoln Synthetic CCD

PatientAbraham Lincoln
Date of birth1994-02-12
IdentifiersMRN HR-NI001-SYN; SSN (made up) 000-01-6683
Document date2026-11-01
AuthorElena Marquez, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Primary care visit for low mood and sleep disturbance. Concerns: Low mood, loss of interest, and poor sleep are affecting legal work and friendships. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sertraline 50 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-06-30activeS
Prednisone 20 mg oral tablet, tapering course: three tablets each morning for 5 days, two for 5 days, then one for 5 daysEach morning with breakfast: 60 mg for 5 days, 40 mg for 5 days, then 20 mg for 5 daysOral route2026-10-09 to 2026-10-23completedS

Immunizations

DateVaccineStatusEvidence
2022-04-11Tdap vaccinecompletedS
2025-10-20Influenza vaccine, 2025-2026 seasoncompletedS
2026-10-27Influenza vaccine, 2026-2027 seasoncompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
Tenth year (about 1818-1819)Kicked by a horse in his tenth year and briefly appeared lifeless; no lasting injury is documentedD (CLM-0004)
January 23, 1841Severe low mood in January 1841, described in his own words as being "the most miserable man living"D (CLM-0005)
Adult lifeRecurrent melancholy retrospectively interpreted as chronic depressionR (CLM-0006)
LifelongTall, slender build retrospectively proposed as Marfan syndrome or another inherited marfanoid disorder; disputed and never genetically confirmedR (CLM-0008)

Family History

RelativeConditionAge at deathEvidence
motherDied of milk sickness (poisoning from milk of cows that ate white snakeroot) in 1818D (CLM-0007)
sisterDied from complications during delivery in 182821D (CLM-0009)

Health Concerns

ConcernStatusEvidence
Low mood, loss of interest, and poor sleep are affecting legal work and friendshipsactiveS

Assessment

Most recent measures: Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 2026-10-27; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 2 on 2026-10-27; Total score [AUDIT-C] 0 on 2026-10-27 [S]

Strengths and supports: Supports: close friend and law colleagues; values correspondence and storytelling [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Major depressive disorder, single episode, moderate; synthetic modern diagnosis linked to documented low mood and its retrospective interpretationactiveprovisional F32.1S — Synthetic active diagnosis for the teaching episode; the historical depression label remains R.
Allergic contact dermatitis from poison ivy, extensive, resolved with a tapering course of prednisoneresolvedconfirmed L23.7S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-30Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]14{score}S
2026-08-11Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S
2026-09-30Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-10-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
2026-10-27Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]2{score}S
2026-10-27Total score [AUDIT-C]0{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-06-30Body height193cmS
2026-06-30Body weight82kgS
2026-06-30Body mass index (BMI) [Ratio]22kg/m2S
2026-06-30Systolic blood pressure118mm[Hg]S
2026-06-30Diastolic blood pressure74mm[Hg]S
2026-06-30Heart rate74/minS
2026-06-30Respiratory rate14/minS
2026-06-30Body temperature36.7CelS
2026-06-30Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-08-11Body height193cmS
2026-08-11Body weight82.4kgS
2026-08-11Body mass index (BMI) [Ratio]22.1kg/m2S
2026-08-11Systolic blood pressure116mm[Hg]S
2026-08-11Diastolic blood pressure72mm[Hg]S
2026-08-11Heart rate70/minS
2026-08-11Respiratory rate14/minS
2026-08-11Body temperature36.8CelS
2026-08-11Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-09-30Body height193cmS
2026-09-30Body weight83kgS
2026-09-30Body mass index (BMI) [Ratio]22.3kg/m2S
2026-09-30Systolic blood pressure114mm[Hg]S
2026-09-30Diastolic blood pressure72mm[Hg]S
2026-09-30Heart rate66/minS
2026-09-30Respiratory rate14/minS
2026-09-30Body temperature36.7CelS
2026-09-30Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-10-09Body height193cmS
2026-10-09Body weight83.2kgS
2026-10-09Body mass index (BMI) [Ratio]22.3kg/m2S
2026-10-09Systolic blood pressure120mm[Hg]S
2026-10-09Diastolic blood pressure74mm[Hg]S
2026-10-09Heart rate72/minS
2026-10-09Respiratory rate14/minS
2026-10-09Body temperature36.8CelS
2026-10-09Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-10-27Body height193cmS
2026-10-27Body weight83.4kgS
2026-10-27Body mass index (BMI) [Ratio]22.4kg/m2S
2026-10-27Systolic blood pressure116mm[Hg]S
2026-10-27Diastolic blood pressure70mm[Hg]S
2026-10-27Heart rate64/minS
2026-10-27Respiratory rate14/minS
2026-10-27Body temperature36.6CelS
2026-10-27Oxygen saturation in Arterial blood by Pulse oximetry99%S

Encounters

DatePurposeStatusProvenance
2026-06-30Primary care visit for low mood and sleep disturbancefinishedS
2026-08-11Six-week depression treatment follow-upfinishedS
2026-09-30Twelve-week depression care-plan reviewfinishedS
2026-10-09Same-day sick visit for a poison ivy rashfinishedS
2026-10-27Adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Use shared decision-making to choose monotherapy for uncomplicated major depression; patient prefers medication over psychotherapycompletedGL-MDD-2022S
Start sertraline 50 mg daily; review expected time to benefit, common adverse effects, and how to reach the cliniccompletedGL-MDD-2022S
Repeat PHQ-9 at six and twelve weeks and adjust treatment if response is inadequate; plan continuation treatment after remissioncompletedGL-MDD-2022S
Create a collaborative safety plan with crisis resources, including the 988 Suicide & Crisis LifelinecompletedGL-SUICIDE-2024S
Psychiatry consultation to confirm the diagnosis and advise on medication managementcompletedGL-MDD-2022S

Goals

GoalTargetStatusOutcomeProvenance
Reduce PHQ-9 score from 14 to below 5 by the twelve-week review2026-09-30completedPHQ-9 score 4S
Take sertraline as prescribed on at least six of seven days each week2026-09-30completedTaken on most days; mild nausea resolved by week threeS
Resume at least two valued activities each week, such as court work and letters to friends2026-08-11completedResumed by the six-week visitS

Functional Status

Mental Status

Structured synthetic safety assessment on 2026-06-30: current ideation absent, intent absent, plan absent. Outpatient care with a collaborative safety plan, crisis resources, and scheduled follow-up [S]